Generation of pure lymphatic endothelial cells from human pluripotent stem cells and their therapeutic effects on wound repair

Shin Jeong Lee, Changwon Park, Ji Yoon Lee, Sangsung Kim, Pil Jae Kwon, Woansang Kim, Yong Heui Jeon, Eugine Lee, Youngsup Yoon

Research output: Contribution to journalArticle

26 Citations (Scopus)

Abstract

Human pluripotent stem cells (hPSCs) have emerged as an important source for cell therapy. However, to date, no studies demonstrated generation of purified hPSC-derived lymphatic endothelial cells (LECs) and tested their therapeutic potential in disease models. Here we sought to differentiate hPSCs into the LEC lineage, purify them with LEC markers, and evaluate their therapeutic effects. We found that an OP9-assisted culture system reinforced by addition of VEGF-A, VEGF-C, and EGF most efficiently generated LECs, which were then isolated via FACS-sorting with LYVE-1 and PODOPLANIN. These hPSC-derived LYVE-1 + PODOPLANIN + cells showed a pure committed LEC phenotype, formed new lymphatic vessels, and expressed lymphangiogenic factors at high levels. These hPSC-derived LECs enhanced wound healing through lymphangiogenesis and lymphvasculogenesis. Here we report, for the first time, that LECs can be selectively isolated from differentiating hPSCs, and that these cells are potent for lymphatic vessel formation in vivo and wound healing. This system and the purified hPSC-derived LECs can serve as a new platform for studying LEC development as well as for cell therapy.

Original languageEnglish
Article number11019
JournalScientific reports
Volume5
DOIs
Publication statusPublished - 2015 Jun 12

Fingerprint

Pluripotent Stem Cells
Therapeutic Uses
Endothelial Cells
Wounds and Injuries
Lymphatic Vessels
Cell- and Tissue-Based Therapy
Wound Healing
Lymphangiogenesis
Vascular Endothelial Growth Factor C
Cell Lineage
Epidermal Growth Factor
Vascular Endothelial Growth Factor A
Phenotype

All Science Journal Classification (ASJC) codes

  • General

Cite this

Lee, Shin Jeong ; Park, Changwon ; Lee, Ji Yoon ; Kim, Sangsung ; Kwon, Pil Jae ; Kim, Woansang ; Jeon, Yong Heui ; Lee, Eugine ; Yoon, Youngsup. / Generation of pure lymphatic endothelial cells from human pluripotent stem cells and their therapeutic effects on wound repair. In: Scientific reports. 2015 ; Vol. 5.
@article{5a571b9abbc640aea46537cbade2bb33,
title = "Generation of pure lymphatic endothelial cells from human pluripotent stem cells and their therapeutic effects on wound repair",
abstract = "Human pluripotent stem cells (hPSCs) have emerged as an important source for cell therapy. However, to date, no studies demonstrated generation of purified hPSC-derived lymphatic endothelial cells (LECs) and tested their therapeutic potential in disease models. Here we sought to differentiate hPSCs into the LEC lineage, purify them with LEC markers, and evaluate their therapeutic effects. We found that an OP9-assisted culture system reinforced by addition of VEGF-A, VEGF-C, and EGF most efficiently generated LECs, which were then isolated via FACS-sorting with LYVE-1 and PODOPLANIN. These hPSC-derived LYVE-1 + PODOPLANIN + cells showed a pure committed LEC phenotype, formed new lymphatic vessels, and expressed lymphangiogenic factors at high levels. These hPSC-derived LECs enhanced wound healing through lymphangiogenesis and lymphvasculogenesis. Here we report, for the first time, that LECs can be selectively isolated from differentiating hPSCs, and that these cells are potent for lymphatic vessel formation in vivo and wound healing. This system and the purified hPSC-derived LECs can serve as a new platform for studying LEC development as well as for cell therapy.",
author = "Lee, {Shin Jeong} and Changwon Park and Lee, {Ji Yoon} and Sangsung Kim and Kwon, {Pil Jae} and Woansang Kim and Jeon, {Yong Heui} and Eugine Lee and Youngsup Yoon",
year = "2015",
month = "6",
day = "12",
doi = "10.1038/srep11019",
language = "English",
volume = "5",
journal = "Scientific Reports",
issn = "2045-2322",
publisher = "Nature Publishing Group",

}

Generation of pure lymphatic endothelial cells from human pluripotent stem cells and their therapeutic effects on wound repair. / Lee, Shin Jeong; Park, Changwon; Lee, Ji Yoon; Kim, Sangsung; Kwon, Pil Jae; Kim, Woansang; Jeon, Yong Heui; Lee, Eugine; Yoon, Youngsup.

In: Scientific reports, Vol. 5, 11019, 12.06.2015.

Research output: Contribution to journalArticle

TY - JOUR

T1 - Generation of pure lymphatic endothelial cells from human pluripotent stem cells and their therapeutic effects on wound repair

AU - Lee, Shin Jeong

AU - Park, Changwon

AU - Lee, Ji Yoon

AU - Kim, Sangsung

AU - Kwon, Pil Jae

AU - Kim, Woansang

AU - Jeon, Yong Heui

AU - Lee, Eugine

AU - Yoon, Youngsup

PY - 2015/6/12

Y1 - 2015/6/12

N2 - Human pluripotent stem cells (hPSCs) have emerged as an important source for cell therapy. However, to date, no studies demonstrated generation of purified hPSC-derived lymphatic endothelial cells (LECs) and tested their therapeutic potential in disease models. Here we sought to differentiate hPSCs into the LEC lineage, purify them with LEC markers, and evaluate their therapeutic effects. We found that an OP9-assisted culture system reinforced by addition of VEGF-A, VEGF-C, and EGF most efficiently generated LECs, which were then isolated via FACS-sorting with LYVE-1 and PODOPLANIN. These hPSC-derived LYVE-1 + PODOPLANIN + cells showed a pure committed LEC phenotype, formed new lymphatic vessels, and expressed lymphangiogenic factors at high levels. These hPSC-derived LECs enhanced wound healing through lymphangiogenesis and lymphvasculogenesis. Here we report, for the first time, that LECs can be selectively isolated from differentiating hPSCs, and that these cells are potent for lymphatic vessel formation in vivo and wound healing. This system and the purified hPSC-derived LECs can serve as a new platform for studying LEC development as well as for cell therapy.

AB - Human pluripotent stem cells (hPSCs) have emerged as an important source for cell therapy. However, to date, no studies demonstrated generation of purified hPSC-derived lymphatic endothelial cells (LECs) and tested their therapeutic potential in disease models. Here we sought to differentiate hPSCs into the LEC lineage, purify them with LEC markers, and evaluate their therapeutic effects. We found that an OP9-assisted culture system reinforced by addition of VEGF-A, VEGF-C, and EGF most efficiently generated LECs, which were then isolated via FACS-sorting with LYVE-1 and PODOPLANIN. These hPSC-derived LYVE-1 + PODOPLANIN + cells showed a pure committed LEC phenotype, formed new lymphatic vessels, and expressed lymphangiogenic factors at high levels. These hPSC-derived LECs enhanced wound healing through lymphangiogenesis and lymphvasculogenesis. Here we report, for the first time, that LECs can be selectively isolated from differentiating hPSCs, and that these cells are potent for lymphatic vessel formation in vivo and wound healing. This system and the purified hPSC-derived LECs can serve as a new platform for studying LEC development as well as for cell therapy.

UR - http://www.scopus.com/inward/record.url?scp=84931261158&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84931261158&partnerID=8YFLogxK

U2 - 10.1038/srep11019

DO - 10.1038/srep11019

M3 - Article

VL - 5

JO - Scientific Reports

JF - Scientific Reports

SN - 2045-2322

M1 - 11019

ER -